THERESA ESPOSITO: Open Payments
NPI 1467057935 · BERGENFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 8 payments from 6 companies in 2025. Trend: 2023 $687 · 2024 $395 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Calliditas Therapeutics US Inc. | 1 | $100 |
| Travere Therapeutics, Inc. | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Ardelyx, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: JYNARQUE, TARPEYO, Filspari, IBSRELA, Fabhalta, FARXIGA.
Industry payments across NJ — which companies pay providers there.
